CM
HSTO

Crestline Management’s Histogen Inc. Common Stock HSTO Stock Holding History

Crestline Management’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,264
Closed -$1.08M – 256
2018
Q2 		$1.08M Buy
+1,264
New +$1.05M 0.11% 190

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Crestline Management's HSTO Position: Q3 2018 in Review

Crestline Management sold out of Histogen Inc. Common Stock (HSTO) in Q3 2018, closing a stake of 1,264 shares — an estimated $1.08M sold.

Crestline Management first reported a position in HSTO in Q2 2018 and held it in 1 quarter. The position peaked at $1.08M in Q2 2018. 55 funds tracked by Wall St. Rank hold HSTO as of Q3 2018.

  • Crestline Management reported no remaining Histogen Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Crestline Management sold 1,264 Histogen Inc. Common Stock shares in Q3 2018, an estimated $1.08M.
  • Crestline Management first reported a position in Histogen Inc. Common Stock in Q2 2018 and held it in 1 quarter.
  • Crestline Management's Histogen Inc. Common Stock position peaked at $1.08M in Q2 2018.
  • 55 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2018.

Based on Crestline Management's 13F filing for Q3 2018, filed 14 Nov 2018.